Sakaki, Japan

Satoru Takeuchi

This inventor holds 1 USPTO granted patent. Top assignee: Kotobuki Pharmaceutical Co Ltd. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoru Takeuchi. Retrieved from https://idiyas.com/inventor/satoru-takeuchi-b2rckspb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Satoru Takeuchi: Innovator in Therapeutic Agents

Introduction

Satoru Takeuchi is a notable inventor based in Sakaki-machi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new therapeutic agents. His work focuses on isoquinuclidine derivatives, which have promising applications in treating hypercholesterolemia.

Latest Patents

Satoru Takeuchi holds 1 patent related to isoquinuclidine derivatives. His patent describes a method of manufacturing these compounds, which are represented by a specific formula or its hydrochloride salts. The compounds exhibit excellent inhibitory activities against squalene synthase, making them valuable as treatment agents for hypercholesterolemia.

Career Highlights

Takeuchi is associated with Kotobuki Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research has the potential to impact the treatment of cholesterol-related health issues significantly.

Collaborations

Some of his coworkers include Tsuyoshi Tomiyama and Akira Tomiyama, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Satoru Takeuchi's work in developing isoquinuclidine derivatives showcases his commitment to advancing therapeutic options in medicine. His contributions are essential in the ongoing fight against hypercholesterolemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…